--- schema_version: "secwatch.filing_event.v1" accession: "0001493152-26-028322" form_type: "8-K" ticker: "PALI" cik: "0001357459" company_name: "PALISADE BIO, INC." filed_at: "2026-06-11T21:23:25+00:00" generated_at: "2026-06-11T21:24:19.646982+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.55 calibrated_materiality_score: 0.55 confidence: "high" source: SEC EDGAR --- # Palisade Bio appoints Jordan Zwick to board; shareholders approve 50% share increase to 450M ## Summary - Jordan Zwick appointed to board, effective June 10, 2026; board expanded from five to six members. - Zwick received initial RSU grant of $566,000, vesting in three equal annual installments. - Stockholders approved amendment to increase authorized common shares from 300M to 450M, effective June 11, 2026. - Stockholders approved Amended and Restated 2021 Equity Incentive Plan (42.257M shares) and Employee Stock Purchase Plan. ## SEC filing metadata - accession: 0001493152-26-028322 - form_type: 8-K - ticker: PALI - cik: 0001357459 - company_name: PALISADE BIO, INC. - filed_at: 2026-06-11T21:23:25+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.55 - calibrated_materiality_score: 0.55 - confidence: high - sec_items: 5.02, 5.07, 5.03, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/form8-k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001493152-26-028322 - JSON: https://secwatch.observer/filing/0001493152-26-028322.json - Plain text: https://secwatch.observer/filing/0001493152-26-028322.txt ## Key facts - Executive change Jordan Zwick was appointed as Director at PALISADE BIO, INC.. - Action: appointed - Role: Director source text: On June 10, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Palisade Bio, Inc. (the “Company”) expanded the size of the Board from five to six directors and appointed Jordan Zwick to the Board. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Governance Changes PALISADE BIO, INC.: Increased authorized shares of common stock from 300,000,000 to 450,000,000 via Certificate of Amendment to Amended and Restated Certificate of Incorporation (effective 2026-06-11). - Change: charter amendment - Effective: 2026-06-11 source text: On June 11, 2026, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock from 300,000,000 shares to 450,000,000 shares. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Approval of an Amendment to the Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock at the 2026-06-10 meeting. - Proposal: charter amendment - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 450,000,000 (which will result in an increase in the total number of authorized shares of capital stock of the Company from 307,000,000 to 457,000,000). evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Approval of the Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan at the 2026-06-10 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders approved the Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Election of Directors at the 2026-06-10 meeting. - Proposal: director election - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders elected the four (4) persons listed below as directors, each to serve until the Company’s 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Approval of equity award grants to our non-employee directors at the 2026-06-10 meeting. - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders approved equity grants to the Company’s non-employee directors. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-06-10 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders ratified the selection of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-10 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm - Shareholder Votes PALISADE BIO, INC. shareholders approved Approval of the Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan at the 2026-06-10 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2026-06-10 source text: The Company’s stockholders approved the Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan. evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315226028322/0001493152-26-028322-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.